President Donald Trump is attempting to slash drug prices for Americans by more closely aligning their costs to lower prices paid abroad, renewing and expanding upon a failed push from his first term. Trump aims to do so by bringing drugmakers to the negotiating table. He signed an executive order Monday asking them to lower prices voluntarily or else face regulatory measures. Pharmaceutical companies had expected — and feared — action on drug prices. However, the order was far weaker than they’d anticipated.
Read the full article: Drugmakers Avoid Worst-Case Scenario as Trump Targets Price Cuts //
Source: https://news.bloomberglaw.com/health-law-and-business/trump-aims-to-cut-drug-costs-by-pegging-to-international-prices